1. Home
  2. TGLS vs TLX Comparison

TGLS vs TLX Comparison

Compare TGLS & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$52.80

Market Cap

2.5B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$6.54

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGLS
TLX
Founded
1984
2015
Country
Colombia
Australia
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
3.3B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TGLS
TLX
Price
$52.80
$6.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$80.00
$21.00
AVG Volume (30 Days)
283.8K
178.9K
Earning Date
02-26-2026
01-19-2026
Dividend Yield
1.15%
N/A
EPS Growth
20.09
N/A
EPS
3.84
0.04
Revenue
$977,886,000.00
$664,225,558.00
Revenue This Year
$12.04
N/A
Revenue Next Year
$10.69
N/A
P/E Ratio
$13.57
$150.68
Revenue Growth
15.70
55.35
52 Week Low
$44.26
$6.40
52 Week High
$90.34
$30.36

Technical Indicators

Market Signals
Indicator
TGLS
TLX
Relative Strength Index (RSI) 54.64 32.43
Support Level $51.81 $6.94
Resistance Level $53.60 $7.43
Average True Range (ATR) 1.66 0.24
MACD 0.30 -0.07
Stochastic Oscillator 66.18 2.66

Price Performance

Historical Comparison
TGLS
TLX

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: